|
NPTN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.972560E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.016300E-03 |
| Normal-vs-Stage2 |
5.810200E-04 |
| Normal-vs-Stage3 |
4.21529999999892E-05 |
| Normal-vs-Stage4 |
4.96849999997995E-06 |
| Stage1-vs-Stage2 |
1.495800E-01 |
| Stage1-vs-Stage3 |
1.220590E-01 |
| Stage1-vs-Stage4 |
3.114300E-02 |
| Stage2-vs-Stage3 |
7.392200E-01 |
| Stage2-vs-Stage4 |
6.173600E-01 |
| Stage3-vs-Stage4 |
3.134200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.70399999999927E-05 |
| Normal-vs-AfricanAmerican |
2.928000E-01 |
| Normal-vs-Asian |
3.694400E-02 |
| Caucasian-vs-AfricanAmerican |
1.366760E-01 |
| Caucasian-vs-Asian |
3.218800E-01 |
| AfricanAmerican-vs-Asian |
5.741600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.975290E-04 |
| Normal-vs-Female |
4.420700E-04 |
| Male-vs-Female |
4.427400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.721900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.211400E-04 |
| Normal-vs-Age(61-80Yrs) |
5.62469999999538E-05 |
| Normal-vs-Age(81-100Yrs) |
5.068100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.701800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.761700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.172400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.767770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.548800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.493200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.149400E-01 |
| Classical-VS-Follicular |
1.521090E-03 |
| Classical-VS-Other |
3.295200E-01 |
| Classical-VS-Normal |
5.616100E-03 |
| Tall-VS-Follicular |
2.588200E-01 |
| Tall-VS-Other |
6.358800E-01 |
| Tall-VS-Normal |
3.678700E-03 |
| Follicular-VS-Other |
9.238200E-01 |
| Follicular-VS-Normal |
2.43859999999874E-05 |
| Other-VS-Normal |
4.601900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26030000000099E-05 |
| Normal-vs-N1 |
1.042690E-04 |
| N0-vs-N1 |
5.801400E-01 |
|
|
